CD8+ T-cell maturation following lung transplantation: The differential impact of CMV and acute rejection

Transplant Immunology

Volumn 18, Issue 2, 2007, Pages 186-192

  Westall, G P ^a,b   Brooks, A G ^c   Kotsimbos, T ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cell differentiation; Cell surface molecules; Cytotoxic T cells; Human; Transplantation

Indexed keywords

CD28 ANTIGEN; GAMMA INTERFERON;

ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; HUMAN; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; PRIORITY JOURNAL; SEROLOGY;

ADULT; ANTIGENS, CD28; BRONCHOALVEOLAR LAVAGE FLUID; CD8-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT REJECTION; HUMANS; LONGITUDINAL STUDIES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VIRAL LOAD;

EID: 36048999804     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.07.002     Document Type: Article

References (21)

1. Appay V., and Rowland-Jones S. Lessons from the study of T-cell differentiation in persistent human virus infection. Semin Immunol 16 (2004) 205-212
2. Arcasoy S.M., and Kotloff R.M. Lung Transplantation. N Engl J Med 340 (1999) 1081-1091
3. Westall G.P., Michaelides A., Williams T.J., Snell G.I., and Kotsimbos T.C. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients. J Infect Dis 190 (2004) 1076-1083
4. Westall G.P., Michaelides A., Williams T.J., Snell G.I., and Kotsimbos T.C. Post lung transplant bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics. Transplantation 75 (2003) 2064-2068
5. Yousem S.A., Berry G.J., Cagle P.T., Chamberlain D., Husain A.N., Hruban R.H., et al. Revision of the 1990 Working Formulation for the Classification of Pulmonary Allograft Rejection: Lung Rejection Study Group. J Heart Lung Transplant 15 (1996) 1-15
6. Kotsimbos A.T.C., Sinickas V., Glare E.M., Esmore D.S., Snell G.I., Walters E.H., et al. Quantitative detection of human cytomegalovirus DNA in lung transplant recipients. Am J Respir Crit Care Med 156 (1997) 1241-1246
7. Jung T., Schauer C., Heusser C., Neuman C., and Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159 (1993) 197-207
8. Michaelides A.E., Facey D., Spelman D.W., Wesselingh S.L., and Kotsimbos T.C. HCMV DNA detection and quantitation in the plasma and PBL of lung transplant recipients: [9] Cobas Amplicor HCMV monitor test versus in-house quantitative HCMV PCR. J Clin Virol 28 (2003) 111-120
9. + T-cells. J Exp Med 186 (1997) 1407-1418
10. Ljungman P., Griffiths P., and Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34 (2002) 1094-1097
11. Sacre K., Carcelain G., Cassoux N., Fillet A., Costagliola D., Vittecoq D., et al. Repertoire, diversity, and differentiation of specific CD8 T-cells are associated with immune protection against human cytomegalovirus disease. J Immunol 201 (2005) 1999-2010
12. + T-cell differentiation in response to viruses. Nat Rev Immunol 3 (2003) 931-939
13. Westall G.P., Kotsimbos T., and Brooks A. CMV-specific T-cell dynamics in the blood and lung allograft reflect viral reactivation following lung transplantation. Am J Transplant 6 (2006) 577-584
14. Zamora M.R., Nicolls M.R., Hodges T.N., Marquesen J., Astor T., Grazia T., and Weill D. Following universal prophylaxis with ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation. Am J Transplant 4 (2004) 1635-1642
15. Humar A., Kumar D., Preiksaitis J., Boivin G., Siegal D., Fenton J., et al. A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients. Am J Transplant 5 (2005) 1462-1468
16. + T-cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8 (2002) 379-385
17. + T-cells from a memory to memory-effector phenotype. J Immunol 168 (2002) 5538-5550
18. - T-cells in heart transplant recipients. Hum Immunol 64 (2003) 31-37
19. - T-suppressor T-cells. Hum Immunol 66 (2005) 252-257
20. - T-cells. Int Immunol 10 (1998) 775-783
21. + tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16 (2004) 1055-1068